Stock listing

NASDAQ:DMTX Dimension Therapeutics Stock

Follow Dimension Therapeutics into a list and get an email when it puts out news.

Last close · NASDAQ:DMTX

$5.95 USD

Close on Nov 6, 2017 · No longer trades

Oct 22, 2015 to last close -44.9% · weekly closes, Oct 22, 2015 – Nov 6, 2017
Lowest – highest close
$1.05 – $15.35 USDSince Oct 22, 2015 · lowest May 26, 2017 · highest Dec 1, 2015

Delisted NASDAQ:DMTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:DMTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Dimension Therapeutics on 6ix

Decks
3 decks · latest Aug 25, 2017

Decks

DeckKindSlidesDate
Merger or Acquisition (August 2017)Merger or acquisition35 slidesAug 25, 2017
Investor Presentation (January 2017)Investor deck28 slidesJan 31, 2017
Investor Presentation (August 2016)Investor deck21 slidesAug 11, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Annalisa Jenkins
Other companies: Skye Bioscience, Inc. (Director · Since at least Feb 29, 2024); Mereo BioPharma Group plc (Director · Since at least Jan 1, 2024); COMPASS Pathways Plc (Director · Since at least Jan 1, 2022); Serina Therapeutics, Inc. (Director · Nov 27, 2018 – Jun 21, 2021 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Ardelyx, Inc. (Director · Apr 20, 2015 – Jun 13, 2019 · Past)
President and CEO, Director · Oct 21, 2015 – Nov 7, 2017 · Past
John Hohneker
Other companies: ArriVent BioPharma, Inc. (Director · Since at least May 16, 2024); Curis, Inc. (Director · Since at least Dec 2, 2021); Carisma Therapeutics, Inc. (Director · Apr 1, 2024 – Jun 26, 2024 · Past); Humanigen Inc (Director · Oct 19, 2021 – Jul 27, 2022 · Past); Aravive Inc (Director · May 12, 2021 – Sep 23, 2022 · Past); Evelo Biosciences, Inc. (Director · Jan 27, 2021 – Jun 8, 2023 · Past)
Director · Jan 18, 2017 – Nov 7, 2017 · Past
Mary Thistle
Other companies: Aktis Oncology, Inc. (Independent Director · Since at least Jan 8, 2026); Cullinan Therapeutics, Inc. (Chair of the Compensation Committee · Since at least Aug 8, 2024); Vigil Neuroscience Inc (Director · Since at least Apr 18, 2022); Entrada Therapeutics, Inc. (Industry Leader and Independent Director · Since at least Oct 28, 2021); Q32 Bio Inc. (Director · Since at least Mar 27, 2018); Alaunos Therapeutics, Inc. (Director · Nov 15, 2020 – Jun 6, 2023 · Past)
Chief Operating Officer · Feb 1, 2017 – Nov 7, 2017 · Past
Michael Dybbs
Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Kalaris Therapeutics, Inc. (Director · Since at least Mar 18, 2025); Nkarta, Inc. (Director · Since at least Jul 9, 2020); Sutro Biopharma, Inc. (Member, Board of Directors · Since at least Sep 26, 2018)
Director · Oct 21, 2015 – Nov 7, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Dimension Therapeutics.